Field Force - KPIs for the New Normal
Participants
Opinions
Field Force - KPIs for the New Normal
Participants
Opinions
Description
In this session Shashin Bodawala takes us through the KPIs that have served well till the COVID19 crisis and how the Key Performance Indicators are changing as pharma companies come to terms with the New Normal
Speaker: Shashin Bodawala, Director – Business Excellence, Go To Market & International Business at Boehringer Ingelheim
Shashin’s current role is to improve customer experience through Go-to-Market initiatives by driving data to deliver insights which translate in appropriate actions.
His team helps the brand teams identify customer segments, deliver customized content, solutions and services on different channels and platforms. His role is to manage these different teams specifically focused on data, digital marketing and capability building.
Shashin also independently manages the International Business for the rest of South Asia.
In the last 10 years, he has had the opportunity to help build and develop a profitable business from scratch. In the last one decade has launched some of largest brands in the market which has eventually created the fastest growing pharmaceutical company (for the last few years) in India
In a career spanning 35 years, he has grown through grassroots to eventually managing large businesses across therapies including Cardiology, Diabetes, Neurology, Urology & Critical care
Share:
Certainly for sales representative sales parameters like to market and in market sales, productivity are the ultimate goals, However the KPIs as discussed here are focussed on work norms, which when executed as planned leads to the required sales results. These are absolutely within the control of the field force and therefore companies can drive these KPIs for all without exception.